MedTrace Logo

Patients on Antithrombotics for Colonoscopy

NCT03363061 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2022-01-18

No results posted yet for this study

Summary

The use of antithrombotics (antiplatelet agents and anticoagulants) is increasing with an aging global population.Management of antithrombotics in patients undergoing invasive procedures including gastrointestinal endoscopy remains a challenge. Management approach includes taking a precarious balance between the risk of thromboembolism after interruption of antithrombotics and risk of bleeding with the continuation of antithrombotics. Colonoscopy remains one of the commonest endoscopic procedures performed. The optimal management strategy of different antithrombotics during colonoscopy remains unclear.

Conditions

  • Antithrombotics
  • Colonoscopy

Sponsors & Collaborators

  • Beijing Friendship Hospital

    collaborator OTHER

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Moe Htet Kyaw, MBBS · Chinese University of Hong Kong

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-08
Primary Completion
2027-11-30
Completion
2028-11-30

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03363061 on ClinicalTrials.gov